Sharma Abhimanyu, Sikka Meera, Gomber Sunil, Sharma Satendra
Dept. of Pathology, University College of Medical Sciences, Delhi, India.
Dept. of Pediatrics, University College of Medical Sciences, Delhi, India.
Iran J Pathol. 2018 Spring;13(2):272-275. Epub 2018 Jul 17.
BACKGROUND & OBJECTIVE: In sepsis, enhanced fibrin formation, impaired fibrin degradation, and intravascular fibrin deposition lead to a prothrombotic state. The current study aimed at measuring various coagulation parameters to predict an early marker for disseminated intravascular coagulation(DIC).
The current prospective study was conducted from January 2012 to April 2013 on 50 children aged 1-10 years with clinically suspected sepsis referred to the Department of Pediatrics of a tertiary care center in New Delhi, India. Patients were evaluated in accordance with criteria for acute infection (ie, symptoms less than seven days) confirmed in all patients in the laboratory. Patients receiving antibiotics 24-48 hours preceding admission were excluded from the study. Prothrombin time, activated partial thromboplastin time, plasma fibrinogen, and D-dimer were measured at the time of admission in 50 patients and 50 controls.
RESULTS & CONCLUSION: D-dimer was positive in 36 (72%) patients and negative in all controls. The difference was statistically significant (<0.01). Plasma fibrinogen was significantly (<0.01) higher in patients compared with the controls. It was decreased in 6% and increased in 8% of the patients, and normal in all controls.PT and APTT were significantly (<0.01) higher in patients compared with the controls.Though none of the current study patients developed overt disseminated intravascular coagulation, the high positivity for D-dimer suggested that it should be measured in children with sepsis for early identification of DIC. This can aid better management as additional coagulation based therapy such as recombinant anti-thrombin and thrombomodulin may help to improve prognosis.
在脓毒症中,纤维蛋白形成增强、纤维蛋白降解受损以及血管内纤维蛋白沉积导致血栓前状态。本研究旨在测量各种凝血参数,以预测弥散性血管内凝血(DIC)的早期标志物。
本前瞻性研究于2012年1月至2013年4月在印度新德里一家三级医疗中心的儿科,对50名年龄在1至10岁、临床疑似脓毒症的儿童进行。根据实验室确诊的所有患者的急性感染标准(即症状少于7天)对患者进行评估。入院前24至48小时接受抗生素治疗的患者被排除在研究之外。对50例患者和50例对照在入院时测量凝血酶原时间、活化部分凝血活酶时间、血浆纤维蛋白原和D-二聚体。
36例(72%)患者的D-二聚体呈阳性,所有对照均为阴性。差异具有统计学意义(<0.01)。与对照组相比,患者的血浆纤维蛋白原显著升高(<0.01)。6%的患者纤维蛋白原降低,8%的患者升高,所有对照均正常。与对照组相比,患者的PT和APTT显著升高(<0.01)。虽然本研究中没有患者发生明显的弥散性血管内凝血,但D-二聚体的高阳性率表明,对于脓毒症患儿应检测D-二聚体以早期识别DIC。这有助于更好地管理,因为诸如重组抗凝血酶和血栓调节蛋白等基于凝血的额外治疗可能有助于改善预后。